Envestnet Portfolio Solutions’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,133
Closed -$282K 1538
2025
Q4
$282K Buy
3,133
+162
+5% +$15.4K ﹤0.01% 1316
2025
Q3
$293K Sell
2,971
-291
-9% -$28.8K ﹤0.01% 1256
2025
Q2
$297K Sell
3,262
-3,158
-49% -$305K ﹤0.01% 1339
2025
Q1
$727K Sell
6,420
-1,823
-22% -$195K ﹤0.01% 909
2024
Q4
$871K Sell
8,243
-275
-3% -$29.5K ﹤0.01% 996
2024
Q3
$920K Buy
8,518
+446
+6% +$48.7K ﹤0.01% 935
2024
Q2
$876K Sell
8,072
-1,698
-17% -$200K ﹤0.01% 901
2024
Q1
$1.29M Sell
9,770
-1,930
-16% -$241K ﹤0.01% 769
2023
Q4
$1.42M Sell
11,700
-3,835
-25% -$428K 0.01% 688
2023
Q3
$1.74M Buy
+15,535
New +$1.97M 0.01% 579

Other funds holding ZBH

Envestnet Portfolio Solutions's ZBH Position: Q1 2026 in Review

Envestnet Portfolio Solutions sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 3,133 shares — an estimated $282K sold.

Envestnet Portfolio Solutions first reported a position in ZBH in Q3 2023 and held it in 10 quarters. The position peaked at $1.74M in Q3 2023. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Envestnet Portfolio Solutions reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Envestnet Portfolio Solutions sold 3,133 Zimmer Biomet shares in Q1 2026, an estimated $282K.
  • Envestnet Portfolio Solutions first reported a position in Zimmer Biomet in Q3 2023 and held it in 10 quarters.
  • Envestnet Portfolio Solutions's Zimmer Biomet position peaked at $1.74M in Q3 2023.
  • 916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q1 2026, filed 29 Apr 2026.